X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2006 | |
| Operating Expenses | 14,825 | 0 |
| Operating Income | -14,825 | N/A |
| Interest Expense | 472 | 0 |
| Other Income | 2,079 | 0 |
| Pre-tax Income | -13,218 | 0 |
| Net Income Continuous | -13,218 | N/A |
| Net Income | $-13,218 | $N/A |
| EPS Basic Total Ops | -4,687.35 | N/A |
| EPS Basic Continuous Ops | -4,681.22 | N/A |
| EPS Diluted Total Ops | -4,687.35 | N/A |
| EPS Diluted Continuous Ops | -4,681.22 | N/A |
| EBITDA(a) | $-14,436 | $N/A |